Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optical Coherence Tomography Angiography in Neurological Disease

NCT: NCT06797765 · COMPLETED

NCT IDNCT06797765
StatusCOMPLETED
Start Date2024-10-20
Completion2026-05-20

Brief Summary

Optical Coherence Tomography Angiography (OCTA) is a non-invasive tool that images the neurovascular structures of the eye by using near-infrared light. Previous literature has demonstrated the potential of OCTA as a screening tool in stroke, but its utility in other neurological illness such as intracranial hemorrhage is unclear. Hence, this pilot study will gather preliminary data to support future grant applications to investigate this area more fully by recruiting patients with neurological illness and healthy controls and comparing their OCTA imaging parameters.

Frequently Asked Questions

What is Optical Coherence Tomography Angiography in Neurological Disease?

Optical Coherence Tomography Angiography in Neurological Disease is a clinical trial registered under NCT06797765. Current status: COMPLETED.

What is the status of NCT06797765?

The current status of NCT06797765 (Optical Coherence Tomography Angiography in Neurological Disease) is: COMPLETED.

When did Optical Coherence Tomography Angiography in Neurological Disease start?

Optical Coherence Tomography Angiography in Neurological Disease started on 2024-10-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.